Cargando…
Efficacy of the small molecule inhibitor of Lipid II BAS00127538 against Acinetobacter baumannii
OBJECTIVE: To test the activity of a small molecule compound that targets Lipid II against Acinetobacter baumannii. METHODS: Susceptibility to small molecule Lipid II inhibitor BAS00127538 was assessed using carbapenem- and colistin-resistant clinical isolates of A. baumannii. In addition, synergy b...
Autor principal: | de Leeuw, Erik PH |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134019/ https://www.ncbi.nlm.nih.gov/pubmed/25143710 http://dx.doi.org/10.2147/DDDT.S68020 |
Ejemplares similares
-
Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant Acinetobacter baumannii in Europe, 2019
por: Lötsch, Felix, et al.
Publicado: (2020) -
Structure–activity exploration of a small-molecule Lipid II inhibitor
por: Fletcher, Steven, et al.
Publicado: (2015) -
Effect of a small molecule Lipid II binder on bacterial cell wall stress
por: Malin, Jakob, et al.
Publicado: (2017) -
Repurposed dihydroorotate dehydrogenase inhibitors with efficacy against drug-resistant Acinetobacter baumannii
por: Russo, Thomas A., et al.
Publicado: (2022) -
Towards Development of Small Molecule Lipid II Inhibitors as Novel Antibiotics
por: Chauhan, Jamal, et al.
Publicado: (2016)